VEA
Virtus ETF Advisers Portfolio holdings
AUM
$75.7M
This Quarter Return
+1.08%
1 Year Return
+23.01%
3 Year Return
+79.79%
5 Year Return
+153.94%
10 Year Return
–
AUM
$335M
AUM Growth
+$335M
(+62%)
Cap. Flow
+$128M
Cap. Flow
% of AUM
38.38%
Top 10 Holdings %
Top 10 Hldgs %
47.51%
Holding
205
New
53
Increased
79
Reduced
42
Closed
30
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
$24M |
| 2 |
iShares Short Treasury Bond ETF
SHV
|
$11.9M |
| 3 |
ETP
Energy Transfer Partners L.p.
ETP
|
$7.87M |
| 4 |
WPZ
Williams Partners L.P.
WPZ
|
$7.16M |
| 5 |
EEP
Enbridge Energy Partners
EEP
|
$5.92M |
Top Sells
| 1 |
Williams Companies
WMB
|
$1.75M |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
$1.69M |
| 3 |
ProShares Ultra 20+ Year Treasury
UBT
|
$1.24M |
| 4 |
TSRO
TESARO, Inc.
TSRO
|
$1.06M |
| 5 |
RPTP
RAPTOR PHARMACEUTICAL CORP COM STK (DE)
RPTP
|
$1.02M |
Sector Composition
| 1 | Energy | 57.29% |
| 2 | Healthcare | 12.14% |
| 3 | Utilities | 3.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Enanta Pharmaceuticals
ENTA
$180M
| $985K | 0.29% |
29,394
+2,745
| +10% | +$92K |
|
52
iShares US Real Estate ETF
IYR
$3.76B
| $978K | 0.29% |
+12,711
| New | +$978K |
|
|
ICPT
53
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $975K | 0.29% |
8,971
+4,593
| +105% | +$499K |
|
|
KERX
54
DELISTED
Keryx Biopharmaceuticals Inc
KERX
| $974K | 0.29% |
166,223
+60,346
| +57% | +$354K |
|
|
TSRO
55
DELISTED
TESARO, Inc.
TSRO
| $973K | 0.29% |
7,233
-7,844
| -52% | -$1.06M |
|
56
United Therapeutics
UTHR
$13.8B
| $972K | 0.29% |
6,777
+973
| +17% | +$140K |
|
57
Theravance Biopharma
TBPH
$699M
| $964K | 0.29% |
30,237
+2,408
| +9% | +$76.8K |
|
58
DTE Energy
DTE
$28.4B
| $960K | 0.29% |
+9,746
| New | +$960K |
|
59
Ionis Pharmaceuticals
IONS
$6.8B
| $946K | 0.28% |
19,777
-8,079
| -29% | -$386K |
|
60
SPDR Bloomberg Convertible Securities ETF
CWB
$4.41B
| $943K | 0.28% |
+20,659
| New | +$943K |
|
61
Nektar Therapeutics
NKTR
$568M
| $943K | 0.28% |
76,834
+35,469
| +86% | +$435K |
|
|
CELG
62
DELISTED
Celgene Corp
CELG
| $935K | 0.28% |
8,081
+1,919
| +31% | +$222K |
|
63
Vanda Pharmaceuticals
VNDA
$279M
| $933K | 0.28% |
58,490
+954
| +2% | +$15.2K |
|
|
ARIA
64
DELISTED
Ariad Pharmaceuticals Inc
ARIA
| $929K | 0.28% |
74,688
-957
| -1% | -$11.9K |
|
65
Biogen
BIIB
$19.4B
| $927K | 0.28% |
3,269
+694
| +27% | +$197K |
|
66
Incyte
INCY
$16.5B
| $916K | 0.27% |
9,137
+1,333
| +17% | +$134K |
|
67
Ironwood Pharmaceuticals
IRWD
$214M
| $914K | 0.27% |
59,798
+11,426
| +24% | +$175K |
|
68
BioMarin Pharmaceuticals
BMRN
$11.2B
| $906K | 0.27% |
10,935
+3,254
| +42% | +$270K |
|
69
Omeros
OMER
$283M
| $901K | 0.27% |
90,858
+34,922
| +62% | +$346K |
|
70
Regeneron Pharmaceuticals
REGN
$61.5B
| $900K | 0.27% |
2,453
+755
| +44% | +$277K |
|
|
PGNX
71
DELISTED
Progenics Pharmaceuticals Inc
PGNX
| $900K | 0.27% |
104,213
-31,127
| -23% | -$269K |
|
72
Gilead Sciences
GILD
$140B
| $885K | 0.26% |
12,361
+4,911
| +66% | +$352K |
|
73
Ligand Pharmaceuticals
LGND
$3.15B
| $885K | 0.26% |
8,714
+3,332
| +62% | +$338K |
|
74
Travere Therapeutics
TVTX
$1.56B
| $883K | 0.26% |
46,654
+9,061
| +24% | +$171K |
|
75
Vertex Pharmaceuticals
VRTX
$100B
| $880K | 0.26% |
11,947
+5,133
| +75% | +$378K |
|